Replimune

0 followers

‌

Replimune is pioneering a new generation of cancer treatments called oncolytic immunotherapies.

Industries

Headquarters

Stage

Employees

Links

Org chart

View full screen

Philip Astley-Sparke

CEO & Chairman

Philip Astley-Sparke

Collapse

Robert Coffin

Founder, President and Chief Research & Development Officer

Colin Love

Chief Operating Officer

Pamela Esposito

Chief Business Officer

Sushil Patel

CCO

Chris Sarchi

Chief Commercial Officer

Kostas Xynos

Chief Medical Officer

Tanya Lewis

Chief Development Operations Officer

Emily Hill

Chief Operating Officer

Teams

View all

CEO and Executive Team

5 members

Leadership Team

5 members

Founding Team

1 members

Discover similar companies

Kymera Therapeutics

2 followers

Cartesian Therapeutics

1 follower

Tempus Labs

12 followers

Ultragenyx Pharmaceutical

5 followers

Biogen

91 followers